NCT03923127View on ClinicalTrials.gov

Transitional Care Study 3

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions
Surgery--Complications
Interventions
OTHER

Elan and HealthDot

Patients with elective surgery will wear two devices (HealthDot and Elan) after surgery in hospital and after discharge at home for up to 2 weeks (HealthDot) or 3 weeks (Elan).

Trial Locations (1)

5623EJ

Catharina Hospital, Eindhoven

All Listed Sponsors
lead

Philips Electronics Nederland B.V. acting through Philips CTO organization

INDUSTRY

NCT03923127 - Transitional Care Study 3 | Biotech Hunter | Biotech Hunter